• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthothiophenes

Recent Advances in the Study of 5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole-2-thiol (CAS: 477887-99-3)

The compound 5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole-2-thiol (CAS: 477887-99-3) has recently emerged as a promising scaffold in medicinal chemistry, particularly in the development of novel therapeutic agents. This heterocyclic compound, featuring a naphthothiophene core fused with an oxadiazole-thiol moiety, has demonstrated significant potential in various pharmacological applications. Recent studies have focused on its synthesis, structural optimization, and biological evaluation, revealing intriguing properties that warrant further investigation.

Structural analysis of 477887-99-3 indicates that the molecule's unique architecture contributes to its diverse biological activities. The naphthothiophene moiety provides a rigid planar structure that facilitates interactions with biological targets, while the oxadiazole-thiol group offers sites for potential derivatization and hydrogen bonding. Computational studies have shown that this compound exhibits favorable drug-like properties, including appropriate lipophilicity and molecular weight, making it a viable candidate for drug development.

Recent pharmacological investigations have highlighted the compound's potential as an antimicrobial agent. In vitro studies against various bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, have demonstrated significant inhibitory activity. The mechanism of action appears to involve interference with bacterial cell wall synthesis, although the exact molecular targets remain under investigation. These findings suggest that 477887-99-3 could serve as a lead compound for developing new antibiotics to address the growing problem of antimicrobial resistance.

In cancer research, preliminary studies have revealed that 5-{4H,5H-naphtho[1,2-b]thiophen-2-yl}-1,3,4-oxadiazole-2-thiol exhibits selective cytotoxicity against certain cancer cell lines, particularly those associated with breast and lung cancers. The compound appears to induce apoptosis through the mitochondrial pathway, as evidenced by changes in caspase activity and Bcl-2 family protein expression. Researchers are currently exploring structure-activity relationships to enhance its potency and selectivity while minimizing potential side effects.

The compound's potential applications extend to neurodegenerative diseases, with recent studies indicating neuroprotective effects in cellular models of Alzheimer's disease. The oxadiazole-thiol moiety may contribute to antioxidant properties, helping to mitigate oxidative stress in neuronal cells. These findings open new avenues for developing therapeutic agents targeting neurodegenerative conditions, although further in vivo studies are necessary to validate these effects.

Synthetic methodologies for 477887-99-3 have been refined in recent years, with several research groups reporting improved yields and purity. Novel catalytic systems and green chemistry approaches have been employed to optimize the synthesis, addressing previous challenges related to scalability and environmental impact. These advancements in synthetic chemistry will facilitate further exploration of this compound's therapeutic potential.

As research progresses, structure-activity relationship (SAR) studies are being conducted to identify key modifications that enhance the compound's pharmacological profile. Current efforts focus on developing derivatives with improved bioavailability and target specificity while maintaining the core structural features responsible for biological activity. These studies are expected to yield valuable insights for medicinal chemistry optimization.

The future research directions for 477887-99-3 include comprehensive pharmacokinetic studies, detailed mechanism of action investigations, and preclinical evaluation in relevant disease models. The compound's diverse biological activities and favorable physicochemical properties position it as a promising candidate for further drug development across multiple therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)